← Leaderboards
George Bigelow
Johns Hopkins University
$12,999,122
Attributed
$14,888,850
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–21$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$21,019,205 · 6
By mechanism
T32$10,007,981 · 1
P50$6,515,471 · 2
UG1$3,001,205 · 1
R01$1,120,328 · 1
K05$374,220 · 1
Top collaborators
- Robert P Schwartz4 shared
- Eric C Strain1 shared
- Elise M Weerts1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- George A Ricaurte$14,201,416
- Maxine L Stitzer$35,973,273
- Mary E McCaul$21,975,059
- Dean Foster Wong$23,186,974
- Dace S. Svikis$8,678,689
Others in their field
Top investigators on “Substance Abuse Problem”
- Lloyd D Johnston · University Of Michigan At Ann Arbor$60,310,192
- Daniel Ernest Ford · Johns Hopkins University$57,520,644
- Edward V Nunes · Columbia University Health Sciences$56,854,926
- Sten H Vermund · University Of Alabama At Birmingham$50,723,449
- Paul Vanveldhuisen · The Emmes Company, Llc$45,589,567
- Walter Nmn Ling · University Of California Los Angeles$42,537,247
Research focus
Substance Abuse ProblemBehavioral PharmacologyClinical ResearchBehavior TherapyHuman SubjectPsychopharmacologyHuman Therapy EvaluationDrug Abuse ChemotherapyBehavioral /Social Science Research TagDosageOpiate AlkaloidFenfluramineCocaineBehavior TestClinical TrialsDrug Screening /EvaluationTryptophanAncillary StudyBehavioral HealthBaseAlcohol Or Other Drugs UseAdoptionClinical TreatmentClinical Research Site
Grant awards (39)
Human Behavioral Pharmacology of Substance Abuse$583,688
T32 · FY2021 · DA
Human Behavioral Pharmacology of Substance Abuse$701,583
T32 · FY2020 · DA · contact PI
Clinical Trials Network: Mid-Atlantic Integrated Care Research Collaborative$1,108,038
UG1 · FY2019 · DA · contact PI
Clinical Trials Network: Mid-Atlantic Integrated Care Research Collaborative$734,897
UG1 · FY2019 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$610,811
T32 · FY2019 · DA · contact PI
Clinical Trials Network: Mid-Atlantic Integrated Care Research Collaborative$407,554
UG1 · FY2019 · DA · contact PI
Clinical Trials Network: Mid-Atlantic Integrated Care Research Collaborative$750,716
UG1 · FY2018 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$614,738
T32 · FY2018 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$573,836
T32 · FY2017 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$1
T32 · FY2017 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$556,768
T32 · FY2016 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$463,070
T32 · FY2015 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$467,104
T32 · FY2014 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$459,633
T32 · FY2013 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$439,461
T32 · FY2012 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$467,999
T32 · FY2011 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$435,803
T32 · FY2010 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$421,745
T32 · FY2009 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$433,716
T32 · FY2008 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$416,940
T32 · FY2007 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$325,778
T32 · FY2006 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$379,279
T32 · FY2005 · DA
Human Behavioral Pharmacology of Substance Abuse$314,138
T32 · FY2004 · DA
Human Behavioral Pharmacology of Substance Abuse$415,586
T32 · FY2003 · DA
TREATMENT RESEARCH CENTER--BEHAVIORAL PHARMACOLOGY$2,104,139
P50 · FY2002 · DA
PHARMACOLOGICAL MODULATION OF COCAINE EFFECTS$383,994
R01 · FY2002 · DA
Human Behavioral Pharmacology of Substance Abuse$377,854
T32 · FY2002 · DA
HUMAN BEHAVIORAL PHARMACOLOGY OF DRUG ABUSE$125,388
K05 · FY2002 · DA
CORE--BEHAVIORAL PHARMACOLOGY$0
P50 · FY2002 · DA
TREATMENT RESEARCH CENTER--BEHAVIORAL PHARMACOLOGY$2,042,865
P50 · FY2001 · DA
PHARMACOLOGICAL MODULATION OF COCAINE EFFECTS$373,339
R01 · FY2001 · DA
Human Behavioral Pharmacology of Substance Abuse$232,953
T32 · FY2001 · DA
HUMAN BEHAVIORAL PHARMACOLOGY OF DRUG ABUSE$124,416
K05 · FY2001 · DA
CORE--BEHAVIORAL PHARMACOLOGY$0
P50 · FY2001 · DA
TREATMENT RESEARCH CENTER--BEHAVIORAL PHARMACOLOGY$1,983,351
P50 · FY2000 · DA
CORE--BEHAVIORAL PHARMACOLOGY$385,116
P50 · FY2000 · DA
PHARMACOLOGICAL MODULATION OF COCAINE EFFECTS$362,995
R01 · FY2000 · DA
HUMAN BEHAVIORAL PHARMACOLOGY OF SUBSTANCE ABUSE$315,497
T32 · FY2000 · DA
HUMAN BEHAVIORAL PHARMACOLOGY OF DRUG ABUSE$124,416
K05 · FY2000 · DA